CMS publishes Medicare physician fee schedule proposal

CMS proposes policy to move away from hospital-based care

The Centers for Medicare & Medicaid Services issued a proposed rule that would update Medicare payment policies and rates for hospital outpatient departments and ambulatory surgical centers, or ASCs, for calendar year 2026.

July 18, 2025

Vol.51 No.28

By Claire Marie Porter

Cancer Policy

ASCO seeks to engage new leaders of NIH, CMS, and FDA

The Association for Clinical Oncology has reached out to the new leaders of federal health agencies to ensure continued progress in cancer care, research, and patient access, the organization said.

Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology

The U.S. Department of Health and Human Services announced that it is making sweeping revisions by cutting personnel, centralizing functions, and consolidating divisions.

March 28, 2025

Vol.51 No.12

By Claire Marie Porter and Jacquelyn Cobb

Clinical Roundup

New payment code and Medicare payment implemented for AI cancer imaging device

Avenda Health, an AI healthcare company, announced the Centers for Medicare & Medicaid Services has assigned a national payment rate for the company’s innovative prostate cancer mapping technology, Unfold AI.

July 26, 2024

Vol.50 No.30

Health Equity

Proposed rule by CMS would expand access to cancer treatment at tribal facilities

The Centers for Medicare and Medicaid Services said it intends to start providing additional reimbursement for some high-cost drugs for people with Medicare who receive care at Indian Health Service or tribal hospitals, beginning Jan. 1, 2025.

July 19, 2024

Vol.50 No.29

By Jacquelyn Cobb

Judiciary News Analysis

Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care

The Supreme Court last week upended one of the underpinnings of administrative law by weakening the authority of federal health agencies to rely on technical expertise as they regulate medical products, issue coverage decisions, and respond to public health crises.

July 05, 2024

Vol.50 No.27

By Matthew Bin Han Ong

CMS publishes Medicare physician fee schedule proposal

YOU MAY BE INTERESTED IN

CMS proposes policy to move away from hospital-based care

ASCO seeks to engage new leaders of NIH, CMS, and FDA

Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology

New payment code and Medicare payment implemented for AI cancer imaging device

Proposed rule by CMS would expand access to cancer treatment at tribal facilities

Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care

Renew today!

Subscriber content

Never miss an issue!

Login

CMS publishes Medicare physician fee schedule proposal

YOU MAY BE INTERESTED IN

CMS proposes policy to move away from hospital-based care

ASCO seeks to engage new leaders of NIH, CMS, and FDA

Kennedy announces massive cuts, centralization at HHS—NCI and FDA hitAlso this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology

New payment code and Medicare payment implemented for AI cancer imaging device

Proposed rule by CMS would expand access to cancer treatment at tribal facilities

Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care

Never miss an issue!

Login

Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology